Medifast Inc. (MED) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Medifast Inc. (MED)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

15.23

-0.48 (-3.06%)

At close: Jan 14, 2025, 3:59 PM

15.20

-0.20%

Pre-market Jan 15, 2025, 06:16 AM EST

undefined% (undefined)

Bid	14.34
Market Cap	166.58M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.67
PE Ratio (ttm)	22.73
Forward PE	n/a
Analyst	Hold

Ask	16.03
Volume	128,246
Avg. Volume (20D)	218,191
Open	15.80
Previous Close	15.71
Day's Range	15.09 - 15.80
52-Week Range	15.09 - 61.07
Beta	undefined

About MED

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life...

[Show more]

Industry Personal Products & Services

Sector Consumer Cyclical

IPO Date Dec 30, 1993

Employees 634

Stock Exchange NYSE

Ticker Symbol MED

Website https://medifastinc.com

Analyst Forecast

According to 1 analyst ratings, the average rating for MED stock is "Hold." The 12-month stock price forecast is $17, which is an increase of 11.62% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Medifast Inc. is scheduled to release its earnings on Feb 18, 2025, during market hours.
Analysts project revenue of $114.25M, reflecting a -40.19% YoY shrinking and earnings per share of -0.16, making a -114.68% decrease YoY.

Why Price Moved

7 months ago · Source

-8.14%

MEDIFAST shares are trading lower after DA Davidso... Unlock content with Pro Subscription

8 months ago · Source

-22.47%

Medifast shares are trading lower after the company reported mixed Q1 financial results.

News

1 week ago · zacks.com

Medifast Launches OPTAVIA ASCEND for Weight Loss Management

MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.

1 week ago · businesswire.com

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product l...

1 month ago · businesswire.com

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independen...

1 month ago · zacks.com

How Should You Play Medifast Stock at a P/E Multiple of 17.6X?

MED is battling customer acquisition challenges and high SG&A costs, while its strategic growth efforts keep it well-positioned for long-term success.

2 months ago · zacks.com

Are Investors Undervaluing MEDIFAST (MED) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 months ago · seekingalpha.com

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Medifast reported better-than-expected quarterly EPS and is investing in new marketing strategies, AI technologies, and supply chain optimization to drive future growth. Despite a decline in the numbe...

2 months ago · zacks.com

MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges

Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.

2 months ago · zacks.com

Medifast (MED) Beats Q3 Earnings and Revenue Estimates

Medifast (MED) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $2.12 per share a year ago.

2 months ago · seekingalpha.com

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Of...

2 months ago · zacks.com

Medifast Gears Up for Q3 Earnings: Here's What You Should Know

MED's Q3 results may reflect customer acquisition challenges and a decline in active earning OPTAVIA Coaches due to the increasing adoption of GLP-1 medications.

2 months ago · businesswire.com

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third...